Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01678001 · ClinicalTrials.gov registry record · Phase 4
Treatment of Plantar Fasciitis With Xeomin
A Phase 4 study of Plantar Fascitis, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01678001 is a Phase 4 study of Plantar Fascitis that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 50 participants, below the 89-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01678001, a Phase 4 study of Plantar Fascitis, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The plantar fascia is an inelastic, broad band of tissue on the plantar or undersurface of the foot. Plantar fasciitis is an inflammation of the plantar fascia that causes heel and foot pain. The current standard orthopaedic management of plantar fasciitis begins with nonsurgical treatment modalities. Surgical treatment of plantar fasciitis is indicated only if nonsurgical means fail. A newer method of treating plantar fasciitis before resorting to surgery is the use of Botulinum Toxin or Xeomin (incobotulinum toxin A, Merz USA). Treatment of plantar fasciitis with Xeomin is important, as there are limited studies on the subject to date. The purpose of this study is to examine the long-term results of using Xeomin to treat plantar fasciitis in one physician's (J.A.) practice at Rothman Institute Orthopaedics through a placebo-controlled, randomized, double-blinded study.
Conditions Studied
Interventions
- DRUG Xeomin
Study Locations (1)
Pennsylvania
- Rothman Institute Orthopaedics - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01678001
The ClinicalTrials.gov registry entry for NCT01678001 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (44% lower). The listed sponsor is Rothman Institute Orthopaedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 1 intervention - of which Xeomin is the first listed.
NCT01678001 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01678001 about?
NCT01678001 is a clinical study titled "Treatment of Plantar Fasciitis With Xeomin". The plantar fascia is an inelastic, broad band of tissue on the plantar or undersurface of the foot. Plantar fasciitis is an inflammation of the plantar fascia that causes heel and foot pain. The current standard orthopaedic management of plantar fasciitis begins with nonsurgical treatment modalit...
What is the current status of trial NCT01678001?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-08. Estimated completion is 2016-08.
What conditions does trial NCT01678001 study?
This clinical trial studies the following conditions: Plantar Fascitis.
What interventions are being tested in trial NCT01678001?
The interventions under investigation include: Xeomin (DRUG).
Who is sponsoring clinical trial NCT01678001?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01678001 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fascitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Versus Static Night Splinting of Plantar Fasciitis
RECRUITING · NA
-
Plantar Fasciitis Randomized Clinical Control Trial
RECRUITING · NA
-
HP Arize 3D Orthotics for Planar Fasciitis
ACTIVE NOT RECRUITING · NA
-
Shockwave Therapy for Plantar Fasciitis RCT
ACTIVE NOT RECRUITING · NA
-
Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy
COMPLETED · NA
-
Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.